LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Eissa, Ahmed M.; Abdulkarim, Ali; Sharples, Gary J.; Cameron, Neil R. (2016)
Publisher: American Chemical Society
Languages: English
Types: Article
Subjects: RM

Classified by OpenAIRE into

mesheuropmc: technology, industry, and agriculture
Synthetic polymer nanoparticles that can be tailored through multivalent ligand display on the surface, while at the same time allowing encapsulation of desired bioactive molecules, are especially useful in providing a versatile and robust platform in the design of specific delivery vehicles for various purposes. Glycosylated nanoparticles (glyco-NPs) of a poly(n-butyl acrylate) (pBA) core and poly(N-2-(β-d-glucosyloxy)ethyl acrylamide) (p(NβGlcEAM)) or poly(N-2-(β-D-galactosyloxy)ethyl acrylamide) (p(NβGalEAM)) corona were prepared via nanoprecipitation in aqueous solutions of preformed amphiphilic glycopolymers. Well-defined block copolymers of (poly(pentafluorophenyl acrylate) (pPFPA) and pBA were first prepared by RAFT polymerization followed by postpolymerization functionalization with aminoethyl glycosides to yield p(NβGlcEAM-b-BA) and p(NβGalEAM-b-BA), which were then used to form glyco-NPs (glucosylated and galactosylated NPs, Glc-NPs and Gal-NPs, respectively). The glyco-NPs were characterized by dynamic light scattering (DLS) and TEM. Encapsulation and release of ampicillin, leading to nanoparticles that we have termed “glyconanobiotics”, were studied. The ampicillin-loaded glyco-NPs were found to induce aggregation of Staphylococcus aureus and Escherichia coli and resulted in antibacterial activity approaching that of ampicillin itself. This glyconanobiotics strategy represents a potential new approach for the delivery of antibiotics close to the surface of bacteria by promoting bacterial aggregation. Defined release in the proximity of the bacterial envelope may thus enhance antibacterial efficiency and potentially reduce the quantities of agent required for potency.\ud \ud
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Cohen, M. L., Nature 2000, 406, 762-767.
    • 2. Walsh, C., Nature 2000, 406, 775-781.
    • 3. Taylor, P. W.; Stapleton, P. D.; Luzio, J. P., Drug Discovery Today 2002, 7, 1086-1091.
    • 4. Miller, K. P.; Wang, L.; Benicewicz, B. C.; Decho, A. W., Chem. Soc. Rev. 2015, 44, 7787-7807.
    • 5. Schrand, A. M.; Rahman, M. F.; Hussain, S. M.; Schlager, J. J.; Smith, D. A.; Ali, S. F., Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2010, 2, 544-568.
    • 6. Rizzello, L.; Cingolani, R.; Pompa, P. P., Nanomedicine 2013, 8, 807-821.
    • 7. Abed, N.; Couvreur, P., Int. J. Antimicrob. Agents 2014, 43, 485-496.
    • 8. Seil, J. T.; Webster, T. J., Int. J. Nanomed. 2012, 7, 2767-2781.
    • 9. Zopf, D.; Roth, S., Lancet 1996, 347, 1017-1021.
    • 10. Ofek, I.; Hasy, D. L.; Sharon, N., FEMS Immunol. Med. Microbiol. 2003, 38, 181-191.
    • 11. Bavington, C.; Page, C., Respiration 2005, 72, 335-344.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article